FCPG Revenue third quarter 2012 Y/Y Growth Comment
First China Pharmaceutical Group, Inc. reported Revenue rise of 49.48% year on year in the third quarter 2012, to $ 17.38 millions, this is lower than First China Pharmaceutical Group, Inc.'s recent average Revenue rise of 73.5%.
Looking into third quarter 2012 results within Healthcare Facilities industry 10 other companies have achieved higher Revenue growth. While First China Pharmaceutical Group, Inc.' s Revenue jump of 49.48% ranks overall at the positon no. 979 in the third quarter 2012.
FCPG Revenue ( Y/Y Growth %)
2012
2011
2010
2009
4th Quarter
December
-
98.05 %
-
-
3rd Quarter
September
49.48 %
-
-
-
2nd Quarter
June
90.11 %
-
-
-
1st Quarter
March
70.97 %
-
-
-
FY
-
462.12 %
-
-
Financial Statements
First China Pharmaceutical Group,'s third quarter 2012 Revenue
Revenue by Quarter for the Fiscal Years 2009, 2010, 2011, 2012
First China Pharmaceutical Group,'s Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
23.89 %
19.5 %
15.1 %
(Sep 30 2012)
FCPG's III. Quarter Q/Q Revenue Comment
First China Pharmaceutical Group, Inc. achieved in the III. Quarter 2012 above company average sequential Revenue jump of 23.91%, to $ 17.38 millions, from $14.03 millions in the second quarter.
Within Healthcare Facilities industry 4 other companies have achieved higher Revenue quarter on quarter growth. While First China Pharmaceutical Group,'s Revenue growth quarter on quarter, overall rank is 320.
First China Pharmaceutical Group, Inc. achieved in the III. Quarter 2012 above company average sequential Revenue jump of 23.91%, to $ 17.38 millions, from $14.03 millions in the second quarter.
Within Healthcare Facilities industry 4 other companies have achieved higher Revenue quarter on quarter growth. While First China Pharmaceutical Group,'s Revenue growth quarter on quarter, overall rank is 320.
First China Pharmaceutical Group,'s 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Sep 30 2012)
12 Months Ending (Jun 30 2012)
12 Months Ending (Mar 31 2012)
12 Months Ending
12 Months Ending
Cumulative Revenue 12 Months Ending
$ 57.83
$ 0.00
$ 12.19
$ 0.00
$ 0.00
Y / Y Revenue Growth (TTM)
73.5 %
-
-
-
-
Year on Year Revenue Growth Overall
Ranking
# 147
# 0
# 0
# 0
#
Seqeuential Revenue Change (TTM)
11.04 %
-
-
-
-
Seq. Revenue Growth (TTM) Overall
Ranking
# 979
# 0
# 0
# 0
#
Cumulative Revenue growth Comment
With 73.5% annual Revenue growth, First China Pharmaceutical Group, Inc. would report a record annual Revenue growth if the fiscal year would end on Sep 30 2012.
Within the Healthcare sector 32 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 147.
With 73.5% annual Revenue growth, First China Pharmaceutical Group, Inc. would report a record annual Revenue growth if the fiscal year would end on Sep 30 2012.
Within the Healthcare sector 32 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 147.
About First China Pharmaceutical Group, Revenue Growth Rates (FCPG), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
83.56%